| 9.3 -0.64 (-6.44%) | 10-10 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 11.35 |
1-year : | 12.21 |
| Resists | First : | 9.72 |
Second : | 10.46 |
| Pivot price | 9.64 |
|||
| Supports | First : | 8.52 |
Second : | 7.09 |
| MAs | MA(5) : | 9.82 |
MA(20) : | 9.56  |
| MA(100) : | 8 |
MA(250) : | 7.33 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 55.5 |
D(3) : | 64.7 |
| RSI | RSI(14): 48.7 |
|||
| 52-week | High : | 10.46 | Low : | 4.57 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CYRX ] has closed above bottom band by 23.9%. Bollinger Bands are 33.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 10.29 - 10.34 | 10.34 - 10.38 |
| Low: | 9.82 - 9.88 | 9.88 - 9.92 |
| Close: | 9.86 - 9.95 | 9.95 - 10.01 |
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
Fri, 10 Oct 2025
CryoPort (NASDAQ:CYRX) Stock Price Crosses Above 200-Day Moving Average - What's Next? - MarketBeat
Tue, 07 Oct 2025
MVE Biological Solutions Launches SmartTag & CryoBeacon with 120‑Day Battery | CYRX Stock News - Stock Titan
Tue, 07 Oct 2025
MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars - PR Newswire
Mon, 29 Sep 2025
CryoPort, Inc. (NASDAQ:CYRX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Wed, 06 Aug 2025
CryoPort Inc (CYRX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
Tue, 05 Aug 2025
Cryoport Reports Second Quarter 2025 Financial Results - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Industrials
|
|
|
Industry:
Integrated Freight & Logistics
|
|
| Shares Out | 50 (M) |
| Shares Float | 41 (M) |
| Held by Insiders | 3.8 (%) |
| Held by Institutions | 101.6 (%) |
| Shares Short | 2,520 (K) |
| Shares Short P.Month | 2,730 (K) |
| EPS | -1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.48 |
| Profit Margin | 31.6 % |
| Operating Margin | -21.3 % |
| Return on Assets (ttm) | -4.3 % |
| Return on Equity (ttm) | -9.2 % |
| Qtrly Rev. Growth | 14.5 % |
| Gross Profit (p.s.) | 2.13 |
| Sales Per Share | 4.75 |
| EBITDA (p.s.) | -0.49 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -17 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | -9.36 |
| PEG Ratio | 0 |
| Price to Book value | 0.98 |
| Price to Sales | 1.96 |
| Price to Cash Flow | -28.02 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|